BSE Live
Sep 05, 16:01Prev. Close
248.20
Open Price
257.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
Cash Flow of Trident Texofab (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 2.58 | 1.17 | 2.73 | 1.27 | 0.90 | |
Net CashFlow From Operating Activities | -13.71 | 2.71 | 5.85 | 1.39 | 1.96 | |
Net Cash Used In Investing Activities | 1.48 | -0.57 | 0.37 | -4.38 | -10.19 | |
Net Cash Used From Financing Activities | 18.03 | -2.05 | -6.20 | 2.99 | 8.19 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 5.80 | 0.09 | 0.02 | 0.00 | -0.05 | |
Cash And Cash Equivalents Begin of Year | -2.64 | 0.06 | 0.04 | 0.03 | 0.08 | |
Cash And Cash Equivalents End Of Year | 3.16 | 0.16 | 0.06 | 0.04 | 0.03 |
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017